Literature DB >> 527636

Plasma protein binding of prednisolone in normal volunteers and arthritic patients.

I T Ağabeyoğlu, R F Bergstrom, W R Gillespie, J G Wagner, D R Kay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 527636     DOI： 10.1007/BF00568200

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  Serum proteins in the aged; means and stability of mucoprotein levels and electrophoretic partitions.

Authors:  E J CHESROW; D BRONSKY; E ORFEI; H DYNIEWICZ; A DUBIN; J MUSCI
Journal:  Geriatrics       Date:  1958-01

2.  Complete amino acid sequence of human serum albumin.

Authors:  B Meloun; L Morávek; V Kostka
Journal:  FEBS Lett       Date:  1975-10-15       Impact factor: 4.124

3.  Comparative bioavailability: eight commercial prednisone tablets.

Authors:  T J Sullivan; M R Hallmark; E Sakmar; D J Weidler; R H Earhart; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-04

4.  Simultaneous competitive protein binding assay for cortissol, cortisone, and prednisolone in plasma, and its clinical application.

Authors:  A K Turner; C J Carroll; J L Pinkus; D Charles; S C Chattoraj
Journal:  Clin Chem       Date:  1973-07       Impact factor: 8.327

5.  Prednisone side-effects and serum-protein levels. A collaborative study.

Authors:  G P Lewis; W J Jusko; L Graves; C W Burke
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

6.  Steroid-protein interactions. 13. Concentrations and binding affinities of corticosteroid-binding globulins in SERA OF MAN, monkey, rat, rabbit, and guinea pig.

Authors:  U Westphal
Journal:  Arch Biochem Biophys       Date:  1967-03-20       Impact factor: 4.013

7.  Conversion of cortisone to cortisol and prednisone to prednisolone.

Authors:  J S Jenkins; P A Sampson
Journal:  Br Med J       Date:  1967-04-22

8.  Clinical pharmacokinetics of aspirin.

Authors:  G Levy
Journal:  Pediatrics       Date:  1978-11       Impact factor: 7.124

9.  Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.

Authors:  L W Powell; E Axelsen
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

10.  Diurnal variation of prednisolone binding to serum corticosteroid-binding globulin in man.

Authors:  A Angeli; R Frajria; R De Paoli; D Fonzo; F Ceresa
Journal:  Clin Pharmacol Ther       Date:  1978-01       Impact factor: 6.875
  10 in total
  7 in total

1.  Generalized pharmacokinetic modeling for drugs with nonlinear binding: I. Theoretical framework.

Authors:  W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1993-02

2.  Estimation of transcortin concentration by measurements of plasma protein-binding of prednisolone and by electroimmunodiffusion.

Authors:  B M Frey; F J Frey
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

3.  Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration.

Authors:  H Bergrem; P Grøttum; H E Rugstad
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Pharmacokinetics of intravenous and oral prednisolone.

Authors:  S Al-Habet; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

5.  Steroid metabolism in isolated rat hepatocytes.

Authors:  J A Morais; J G Wagner
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Oct-Dec       Impact factor: 2.441

6.  The effect of prednisone and hydrocortisone on the plasma protein binding of prednisolone in man.

Authors:  U F Legler; L Z Benet
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  The binding of prednisolone in human serum and to recrystallized human albumin in vitro.

Authors:  W H Steele; G M Hawksworth; H E Barber
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.